Symbol: |
VTCN1
|
Description: |
V-set domain containing T cell activation inhibitor 1 [Source:HGNC Symbol;Acc:28873]
|
Location: |
Chr1:117686209-117753556[-]
|
CRmiRSNP:
~ Export ~
|
Records:null
Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
Compound:
~ Export ~
|
Records:110
Gene |
Compound |
Gen_sig |
Exp_pattern |
VTCN1 |
Ethanesulfonic acid, compd. with 4-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)-m-hydrocinnamotoluidide (1:1) |
0.048 |
Up |
VTCN1 |
L-Aspartic acid, N-[4-[[(2-amino-4-hydroxy-6-quinazolinyl)methyl]amino]benzoyl]-, monohydrate |
0.033 |
Up |
VTCN1 |
9-METHOXYCAMPTOTHECIN |
0.021 |
Up |
VTCN1 |
NSC 191393 |
0.021 |
Down |
VTCN1 |
5-CHLORO-6-[[(3,4-DICHLOROPHENYL)AMINO]METHYL]-2,4-QUINOZOLINEDIAMINE |
0.026 |
Up |
VTCN1 |
2,6-Pyridinedicarbonitrile, 3,4,5-tris(phenylthio)- |
0.04 |
Up |
VTCN1 |
Mitoxantrone |
0.03 |
Up |
VTCN1 |
1H-Benz[g]indazole-3-carboxamide,1-(4-chlorophenyl)- N-[2-(diethylamino)ethyl]-4,5-dihydro-7-methoxy-, monohydrochloride |
0.015 |
Down |
VTCN1 |
2,4-Pyrimidinediamine, 5-(4-chloro-3-nitrophenyl)-6-ethyl- |
0.019 |
Up |
VTCN1 |
7H-Pyrrolo[3,2-f]quinazoline-1,3-diamine, 7-[(4-aminophenyl)methyl]-, dihydrochloride |
0.045 |
Up |
VTCN1 |
1-Propanone, 3-(dimethylamino)-2-[(dimethylamino)methyl]-1-(4-methoxyphenyl)-, dihydrochloride |
0.039 |
Down |
VTCN1 |
1-Piperazinecarboselenoic acid, 4-(2-pyridinyl)-, [1-(2-pyridinyl)ethylidene]hydrazide |
0.03 |
Down |
VTCN1 |
CHAETOCHROMIN |
0.016 |
Up |
VTCN1 |
PHYTOENE |
0.02 |
Up |
VTCN1 |
NSC 404886 |
0.006 |
Up |
Expression pattern: Sensitivity / Resistance
Total:8 Current:1
[First] [Prev]  Next Last 
|
SNP:
~ Export ~
|
Records:17
Total:2 Current:1
[First] [Prev]  Next Last 
|
miRNA:
~ Export ~
|
Records:39
Total:3 Current:1
[First] [Prev]  Next Last 
|